Previous 10 | Next 10 |
Brainsway (NASDAQ: BWAY ): Q4 GAAP EPS of -$0.10 beats by $0.02 . More news on: Brainsway Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...
PATTERSON, N.J., March 23, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, today reported financial results for the quarter and full-year ...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
PATTERSON, N.J., March 11, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, today announced that it will report its Fourth Quarter and Full...
TAMPA, Fla., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Solace Behavioral Health , a mental health clinic offering advanced treatments for mental health disorders, announced today that it will host an grand opening to formally introduce its latest treatment offering, BrainsWay’s Deep Tra...
Results demonstrate increased activity in attention-related brain networks treated with BrainsWay’s H6-coil, which correlate with observed improvement in ADHD symptoms PATTERSON, N.J., Feb. 10, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay&...
PRESCOTT VALLEY, Ariz., Feb. 06, 2020 (GLOBE NEWSWIRE) -- West Yavapai Guidance Clinic , a non-profit mental health facility offering advanced treatments for behavioral and mental health disorders, announced today that it will host an open house to formally introduce its latest treatment...
PATTERSON, N.J., Feb. 06, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”) today announced interim results from a multicenter randomized controlled double-blind clinical trial assessing the safety and efficacy of the Company’s H7-coil deep...
ST. LOUIS, Feb. 04, 2020 (GLOBE NEWSWIRE) -- Greenbrook TMS NeuroHealth Centers , a leading provider of Transcranial Magnetic Stimulation (TMS) in the United States, is now offering BrainsWay’s Deep TMS Therapy for obsessive-compulsive disorder (OCD) in facilities around the S...
CARY, N.C., Jan. 21, 2020 (GLOBE NEWSWIRE) -- Greenbrook TMS NeuroHealth Centers , one of the leading providers of Transcranial Magnetic Stimulation (TMS) therapy in the United States, announced today that it is now offering BrainsWay’s Deep TMS therapy for patients with obses...
News, Short Squeeze, Breakout and More Instantly...
2024-07-16 23:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
BURLINGTON, Mass. and JERUSALEM, June 17, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced its broad market...